Understand the source comparison
Glow Stack Peptides: Clinical Comparison
GHK-Cu (Copper Peptide) Stimulates collagen I/III synthesis via TGF-beta pathway, chelates copper to activate lysyl oxidase (crosslinks collagen) 500mcg subcutaneous Once daily (evening) 28 days at 2–8°C Best for visible skin texture improvement and fine line
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- GHK-Cu (Copper Peptide)
- Stimulates collagen I/III synthesis via TGF-beta pathway, chelates copper to activate lysyl oxidase (crosslinks collagen)
- 500mcg subcutaneous
- Once daily (evening)
- 28 days at 2–8°C
- Best for visible skin texture improvement and fine line reduction. Clinical trials show 18–30% increase in dermal thickness after 12 weeks
- BPC-157
- Accelerates angiogenesis (new blood vessel formation), enhances fibroblast migration to wound sites, upregulates VEGF
- 250–500mcg subcutaneous
- Twice daily (split dose)
- Most effective for acute skin repair and barrier restoration. Half-life of ~4 hours requires split dosing for sustained effect
- TB-500 (Thymosin Beta-4)
- Promotes actin polymerisation, increases cellular mobility, reduces inflammatory cytokines (IL-6, TNF-alpha)
- 2mg subcutaneous
- Twice weekly
- Long-acting systemic support for collagen remodelling. Use in later cycle phases to prevent receptor saturation from daily peptides
- The comparison shows why rotation matters. GHK-Cu and BPC-157 both target fibroblast activity but through different signalling pathways. Using them together doesn't double the effect, it saturates the same downstream collagen synthesis machinery. TB-500's twice-weekly schedule maintains background support without interfering with the acute signalling from daily peptides.